Search Results for "Dubuque Regional Airport π² ππ ππππππ‘ππ π β¬ Official Site Number"
Tse has been working in the virology field since he was an undergraduate student, from bacteriophages to pathogenic human viruses. His research focuses on the basic virology and vaccinology of negative sense RNA viruses, including influenza, dengue and Coronaviruses. He also engaged in the practical applications of adeno-associated viruses (AAVs), which are the safest vectors for gene therapy applications.Β
Tse's major contributions include the development of the next generation AAV capsids that are able to evade neutralizing antibodies, increase transduction efficiency, and target specific tissues. His work on AAV has led to three first-author publications and two patent applications licensed to StrideBio. Tse has performed extensive research on influenza pathogenesis and vaccine developmentΒ and discovered three independent influenza activation pathways by alternative host and bacterial proteases.
Mark Holmes, PhD, is a Professor in the Department of Health Policy and Management in the University of North Carolina Gillings School of Global Public Health and Director of the Cecil G. Sheps Center for Health Services Research, where he is also the Director of the North Carolina Rural Health Research and Policy Analysis Center and the Co-Director of the Program on Health Care Economics and Finance at the Cecil G. Sheps Center for Health Services Research.
His interests include hospital finance, rural health, workforce, health policy, and patient-centered outcomes research.
In 2014, he received the Phillip and Ruth Hettleman Prize for Artistic and Scholarly Achievement by Young Faculty. In 2015 he was named Outstanding Researcher by the National Rural Health Association.Β Previously, he was Vice President of the North Carolina Institute of Medicine, where he gained experience in North Carolina health policy. He previously served on the board of the North Carolina Health Insurance Risk Pool. His state policy work led to his 2010 Health Care Hero "Rising Star" award from the Triangle Business Journal. He is a member of the Editorial Boards of the Journal of Rural Health and the NCMJ. He received his BS in Mathematics and Economics from Michigan State University and his PhD from the Department of Economics at UNC-Chapel Hill.
Dr. Hursting is Professor in the Department of Nutrition and the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill. He is also Professor at the UNC Nutrition Research Institute in Kannapolis, NC. He earned his PhD in nutritional biochemistry and MPH in nutritional epidemiology from UNC-Chapel Hill, and he completed postdoctoral training in molecular carcinogenesis and cancer prevention at the National Cancer Institute (NCI). Prior to joining the UNC faculty in 2014, Dr. Hursting was Professor and Chair of the Department of Nutritional Sciences at the University of Texas (UT) at Austin, the McKean-Love Endowed Chair of Nutritional, Molecular and Cellular Sciences in the UT College of Natural Sciences, and Professor of Molecular Carcinogenesis at the UT-MD Anderson Cancer Center (2005-14). He also previously served as Deputy Director of the NCIβs Office of Preventive Oncology and Chief of the NCIβs Nutrition and Molecular Carcinogenesis Laboratory Section (1999-2005). An international leader in the area of nutrition, obesity, metabolism and cancer, his lab focuses on the molecular and metabolic mechanisms underlying obesity-cancer associations, and the impact of obesity- energy balance modulation (eg, calorie restriction and exercise) or pharmacologic agents on cancer development, progression, and responses to chemotherapy. Primarily using genetically engineered mouse models of breast cancer (recently in parallel with several clinical trials), colon cancer and pancreatic cancer, Dr. Hursting has identified the IGF1/Akt/mTOR and NF-kB signaling pathways as key targets for breaking the obesity-cancer link. His publications establish causal links between obesity, cancer and several systemic factors (including IGF-1, insulin, leptin and IL-6) and components of their downstream signaling pathways (including mTOR and NF-kb).Β
Joseph Piemont (Joe) is a C-suite leader, effective Board Director and management team partner, accomplished in all facets of integrated healthcare system strategy, development and operations. He built and led one of the nationβs largest public, not-for-profit healthcare and regional patient care systems, creating an $8.7B market leader. Leveraging more than 20 years of experience in healthcare, Joe is most known for his ability to produce high performance results - financially, clinically, and culturally, with a strong focus and commitment to transforming healthcare delivery and care management. Joe brings long-term knowledge of the changing healthcare industry and patient needs, he has navigated growth and downturn markets maximizing business value and team potential to meet the highest patient quality and care standards.
Most recently, Joe served as President and COO at Carolinas Healthcare System (βCHSβ), from 2007-2015. He was promoted from earlier Business Development, division President and General Counsel roles, which he held with CHS. Throughout his tenure, Joe drove regional growth principally across North and South Carolina, extending into Georgia. He transformed this enterprise, designing and implementing innovative business strategy and applying business models that enabled system affiliation with providers across the three states. He led growth initiatives taking the organization from 13 owned, managed or leased hospitals in 1997, to one of the largest healthcare systems in the nation by 2015, with 900+ care centers and close to $9B in net annual operating revenue. Under his leadership, the organization built and scaled operations accommodating more than 11M patient encounters per year, 2M+ active primary care patients and 60K teammates. CHS also delivered annual charity care and community benefits approximating $1.6B.
Joe built his healthcare leadership expertise in earlier roles with Coastal Physician Group, Inc., where he progressed to President, Chief Executive Officer and Board Director, from Executive Vice President, Administration and General Counsel. He was appointed by, and reported to, the Board of Directors, leading turnaround efforts during crisis at this publicly-traded company. Earlier in his career, Joe worked in banking and the legal profession with AMRESCO Holdings, Inc., as General Counsel and Secretary, NationsBank of Texas, N.A., as Associate General Counsel, Bluestone Management Corporation, as Managing Director and Associate, and Cannon & Blair, P. A., as Associate Attorney and of Counsel.
Since 1996, Joe has served in multiple Board of Director roles for corporate and not-for-profit entities, including Board Director for publicly-traded Coastal Physician Group and a number of community organizations including the YMCA of Greater Charlotte, World Affairs Council Charlotte, and The Charlotte Chamber of Commerce.
Joe received his JD from Emory University School of Law and his BA in Economics from the University of North Carolina β Charlotte. His career took him to Texas and the Southeastern United States, and Joe currently resides in Charlotte, NC.
In addition to serving as Institute for Global Health and Infectious Diseases (IGHID) director, Dr. Cohen is the Yeargan-Bate Eminent Professor of Medicine, Microbiology and Immunology and Epidemiology at UNC.
In 2007 he was appointed Associate Vice Chancellor for Health Affairs. Dr. Cohen has served as the Director of the UNC Division of Infectious Diseases since 1988 and is associate director of the UNC Center for AIDS Research. Dr. Cohenβs research focuses on the transmission and prevention of HIV, with emphasis on the role played by STD co-infections.
Dr. Cohen is the architect and principal investigator of the multinational HIV Prevention Trials Network (HPTN) 052 study, which demonstrated that antiretroviral treatment prevents the sexual transmission of HIV-1. This work was recognized by Science Magazine as the βBreakthrough of the Yearβ in 2011. He is a member of the Institute of Medicine, the American Society of Clinical Investigation and the American Association of Physicians.
Dr. Lamichhane is trained in the nutritional and environmental epidemiology of chronic diseases. Her primary areas of interest include exploring the role of individual-level determinants (such as nutritional factors) as well as the roles of contextual-level determinants (such as built food environment and environmental exposures) in the epidemiology of diabetes, obesity and cardiovascular disease.
Recently, she is exploring the role of air pollution exposure in the development of diabetes/glucose homeostasis using longitudinal study cohort populations. In addition, she is interested in exploring whether individual-level diet and PA behaviors modify the environmental exposure-diabetes association. These findings will help researchers understand potential common mechanisms by which these multilevel factors influence health outcomes. Further, the findings will inform intervention strategies to promote health behaviors as well as inform regulation policies for environmental exposures.
Dr. Anissa I. Vines's commitment to health equity is evident across her research, teaching, and public health practice. She has extensive experience in developing and leading initiatives to reduce and eliminate health disparities and conducting both community-engaged and epidemiological research. Dr. Vines is an associate professor and a member of the social epidemiology program in the Department of Epidemiology at UNC-Chapel Hill. She has a secondary appointment in Academic Affairs in the UNC Gillings School of Global Public Health and an adjunct appointment in the Department of Social Medicine in the UNC School of Medicine. Dr.Vines leads the Health Equity, Social Justice, and Human Rights concentration for the Gillings MPH program and serves as course coordinator for the school-wide SPHG-600 graduate course β Introduction to Public Health. Dr. Vines has been a member of the UNC Lineberger Comprehensive Cancer Center for 18 years, and also serves as a member in the UNC Womenβs Health Research Center, and an associate faculty member at the UNC Center for Health Equity Research.Β
Kristin L. Reiter, PhD, is Professor and Chair of the Department of Health Policy and Management, and Research Fellow at the Cecil G. Sheps Center for Health Services Research, both at the University of North Carolina at Chapel Hill.
Dr. Reiter teaches courses in healthcare financial management and management accounting and is involved in several research projects, including the Rapid Response to Requests for Rural Data Analysis and Issue-Specific Rural Research Studies and the Rural Hospital Flexibility Program Evaluation, both funded by the Federal Office of Rural Health Policy. She has authored or co-authored over 50 peer-reviewed publications, and is co-author of a leading textbook in healthcare finance.
Prior to receiving a PhD in health services organization and policy, Dr. Reiter worked as an auditor for a large public accounting firm.
